Pharmaspectra

What Pharmaspectra does

Pharmaspectra is a global provider of medical affairs data and AI-powered Key Opinion Leader (KOL) identification, profiling, and impact-measurement solutions for pharmaceutical and biotech Medical Affairs teams. The platform operates as a subsidiary brand under IQVIA (NYSE: IQV) and was founded in 2005, with a headcount of 101–250 employees and headquarters in New York. Its core products include the Expert Ecosystem (multi-domain expert profiling), Share of Scientific Voice™ (SoSV, a validated Medical Affairs measurement framework), Scientific Meetings Data (covering 43,000 meetings and 2.13 million abstracts per year across 115+ countries), and Data-driven KOL Identification. The technology stack combines natural language processing (NLP) tuned for unstructured scientific and field-medical text, AI-driven Patient & Healthcare Provider (HCP) profiling, and a proprietary IQVIA Medical Reasoning LLM (Med-R1 8B).

Pharmaspectra's business model is enterprise SaaS delivered via direct field sales, with prospective clients required to request platform demos or callbacks to access commercial terms; no self-service or publicly disclosed pricing exists. Customers are enterprise pharmaceutical and biotech Medical Affairs organizations — including Medical Science Liaisons, Medical Directors, and Medical Affairs leadership — with Sanofi cited as a named enterprise customer. The platform targets KOL identification, expert engagement strategy, scientific communications measurement, and Medical Affairs strategic planning across the product lifecycle, positioning itself around validated measurement methodology and a 55%-pre-event abstract availability rate as a functional differentiator.

Strategic positioning is reinforced by IQVIA's global commercial footprint across the Americas, Europe, Asia & Oceania, and the Middle East & Africa, by analyst recognition as a leader in Medical Affairs Strategy, and by a partnership with NVIDIA to co-develop AI agents for life sciences. Leadership includes a CCO (Julian Tompkins), CMO (David Kelaher), COO (Simon Mason), and Co-Founder Yan Barshay as Chief Client Experience Officer. Direct financial disclosures — standalone revenue, ARR, or bookings — are not available in the provided sources, limiting standalone valuation inference.

Name

Pharmaspectra

Legal name

Pharmaspectra

Website

https://pharmaspectra.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharmaspectra is an enterprise SaaS platform, operating under IQVIA, that provides AI-powered KOL identification, expert profiling, and Medical Affairs impact measurement for pharmaceutical and biotech Medical Affairs teams across 115+ countries.

Ownership category

akta.pro rank

Product category

Medical Affairs Analytics Software

NAICS

Software Publishers (51321)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

Keywords

• Medical affairs analytics
• KOL identification software
• Scientific meetings data
• Healthcare data analytics
• Real-world evidence platform

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Platform Subscription: Enterprise SaaS platform subscription model for Medical Affairs KOL identification and impact measurement services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Pharmaspectra provides an enterprise SaaS platform for pharmaceutical and biotech Medical Affairs teams to identify, profile, engage, and measure Key Opinion Leaders (KOLs) across the product lifecycle. Its core offerings include the Expert Ecosystem unified multi-domain expert profiling platform, the Share of Scientific Voice (SoSV) validated impact measurement framework, and a Scientific Meetings Data service covering 115+ countries, 43,000+ scientific meetings, and 2.13M meeting abstracts annually, powered by IQVIA Healthcare-grade AI and NLP.

Product overview

Pharmaspectra is a unified platform providing comprehensive KOL identification, profiling, and impact measurement solutions for Medical Affairs teams. The platform comprises Expert Ecosystem for multi-domain expert profiling, Share of Scientific Voice™ (SoSV) for validated impact measurement, and scientific meetings data monitoring 115+ countries and 43,000 annual scientific meetings with 2.13 million meeting abstracts uploaded each year. IQVIA is recognized as a leader in Medical Affairs strategy according to independent market research.

Differentiator

Problem solved

Functional benefit

Products and services

• Expert Ecosystem Unified multi-domain expert profiling platform that enables more accurate KOL identification, strategic planning, engagement tracking, and measurement of KOL activities across the product lifecycle, targeted at pharmaceutical and biotech Medical Affairs teams.
• Share of Scientific Voice™ (SoSV) Validated measurement framework that enables monitoring and modifying of Medical Affairs strategic planning for optimal effectiveness and impact throughout the product lifecycle, used by pharmaceutical and biotech Medical Affairs teams.
• Scientific Meetings Data Data service providing easy access to meeting abstracts (with 55% of large meeting abstracts available before the event), personalized alerts for staying current with science, and discovery of new KOLs and rising stars, used by Medical Affairs teams in pharmaceutical and biotech organizations.
• Data-driven KOL Identification Comprehensive expert engagement strategy offering informed by trusted scientific data, methodologies, and best-in-class technology for identifying and engaging key opinion leaders throughout the product lifecycle, targeted at pharmaceutical and biotech Medical Affairs teams.

Quantifiable outcome

• 55% of large meeting abstracts available before the event
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

One partnership is on record.

• NVIDIAcoreTechnology or IntegrationIQVIA collaborating with NVIDIA to launch AI agents for life sciences. IQVIA's custom-built AI agents using NVIDIA technology are designed to enhance workflows and accelerate insights for life sciences organizations.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Within3: Within3 is a SaaS platform for KOL engagement, advisory boards, and Medical Affairs insights management. It directly overlaps Pharmaspectra's Expert Ecosystem and SoSV-style impact-measurement value proposition for pharma Medical Affairs teams.
• Monocl: Monocl (now part of Definitive Healthcare) offers an expert and KOL platform built on publications, grants, and clinical evidence. It competes directly with Pharmaspectra's expert profiling and scientific-impact analytics for Medical Affairs teams.
• H1 (H1 Insights): H1 provides a healthcare professional and KOL data platform with profiles, publications, and clinical trial activity. It is the closest direct competitor to Pharmaspectra's expert profiling and scientific-voice measurement offerings for pharma commercial and Medical Affairs buyers.

Emerging players

• Sermo: Sermo operates a physician social network and HCP insights platform that pharma uses for KOL identification, advisory boards, and real-world physician sentiment. It overlaps with Pharmaspectra's KOL identification and expert-engagement use cases for Medical Affairs teams.

Broad incumbents

• Citeline (Informa Pharma Intelligence): Citeline delivers pharma intelligence across pipeline, trials, and drug development. While broader than Pharmaspectra, it is a comparable enterprise data/informatics vendor to Medical Affairs and commercial strategy teams at pharma/biotech.
• Veeva Systems: Veeva is the dominant cloud platform for life sciences, with Veeva Vault spanning Medical Affairs, CRM, regulatory, and clinical. It competes head-on with Pharmaspectra in Medical Affairs content/engagement and serves the same enterprise pharma customers with a broader suite.
• IQVIA (parent/broad incumbent): IQVIA is Pharmaspectra's parent company and the broader incumbent in RWE, clinical research, and healthcare data. It is the ultimate competitive context for any investment/partnership thesis on Pharmaspectra, since all commercial distribution is run through IQVIA channels.
• Definitive Healthcare: Definitive Healthcare provides commercial intelligence, including HCP/KOL data and affiliations, to life sciences and healthcare buyers. Its analytics platform is a comparable intelligence vendor competing for pharma Medical Affairs wallet share.

Regional players

• MedThink Communications: MedThink is a medical communications and Medical Affairs agency delivering KOL engagement, scientific content, and MSL support to pharma clients. It is comparable to Pharmaspectra as an alternative KOL/Medical Affairs solutions provider to pharma brand teams.
• AlphaGroup (AlphaBioCom): AlphaGroup is a medical communications and Medical Affairs services firm offering scientific platforms, KOL engagement, and medical education. It overlaps with Pharmaspectra's KOL engagement and Medical Affairs impact measurement, particularly as a services-led alternative.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pharmaspectra

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaspectra